Minimally invasive liver resection to obtain tumor-infiltrating lymphocytes for adoptive cell therapy in patients with metastatic melanoma

BACKGROUND: Adoptive cell therapy (ACT) with tumor-infiltrating lymphocytes (TIL) in patients with metastatic melanoma has been reported to have a 56% overall response rate with 20% complete responders. To increase the availability of this promising therapy in patients with advanced melanoma, a mini...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Alvarez-Downing, Melissa M, Inchauste, Suzanne M, Dudley, Mark E, White, Donald E, Wunderlich, John R, Rosenberg, Steven A, Kammula, Udai S
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3408344/
https://ncbi.nlm.nih.gov/pubmed/22726267
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-7819-10-113
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares